Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 19Neurofibroma, Plexiform 11Neurofibrosarcoma 3Sarcoma 1Peripheral Nervous System Diseases 1Pain 1Optic Nerve Glioma 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neuroblastoma 1Neoplasms, Nerve Tissue 1Meningioma 1Lymphoma, Non-Hodgkin 1Heredodegenerative Disorders, Nervous System 1Glioma 1Ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Oxycodone 2Methadone 2Fentanyl 2Analgesia 2Acupuncture Therapy 2ziprasidone 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Uncertainty 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sevelamer 1Saline Solution 1Rocuronium 1Remifentanil 1Psychosocial Intervention 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Nifedipine 1Nafcillin 1Morphine 1Molindone 1Methylprednisolone 1Lurasidone Hydrochloride 1Labetalol 1Haloperidol 1Gelclair 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × AZD 6244 × CNS × Clear all
NCT01362803 2026-06-01

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
99 enrolled 1 FDA
CNS

Neurofibromatosis 1, Pain, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡